Oorsprong van het eerstegraads netwerk van Ellen van Rooijen
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.
34
| Private Company | Investment Managers | 34 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ellen van Rooijen via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Thomas Jefferson University | College/University | Corporate Officer/Principal | |
| MOLECULAR PHARMACOLOGY (USA), LTD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Mascoma Corp.
 Mascoma Corp. BiotechnologyHealth Technology Mascoma Corp. develops technology for abundant biomass conversion. The firm operates through its bioprocessing technology platform, develops bioengineered yeasts and other microorganisms. It also designs and manufactures equipment that processes cellulosic biomass for further biological or chemical conversion. The company was founded by Lee R. Lynd, Charles E. Wyman and Robert J. Johnsen in 2005 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal President | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Director/Board Member | |
| The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Guelph | College/University | Doctorate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
| Sidney Kimmel Medical College | College/University | Corporate Officer/Principal | |
Institute of Human Virology
 Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Other Consumer Services | Chairman | |
| Johnson & Johnson Pharmaceutical Group | Corporate Officer/Principal | ||
| Tibotec Pharmaceuticals | Chief Executive Officer | ||
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Chairman | |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Midori USA, Inc.
 Midori USA, Inc. Miscellaneous Commercial ServicesCommercial Services Midori USA, Inc. develops cellulosic technology for conversion of biomass to fuels. It offers biomass barrier technology that melts and digests biomass into sugars with a solid, recyclable catalyst. The company was founded by J. M. Geremia and Brian Baynes in 2008 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
LFB USA, Inc.
 LFB USA, Inc. Pharmaceuticals: MajorHealth Technology LFB USA, Inc. is a pharmaceutical company based in Framingham, MA. The company develops and provides pharmaceutical bioproducts through innovative technologies for patients with serious diseases. LFB USA is committed to improving people's lives by overcoming barriers through purposeful science. The company offers a robust set of services that powers its own pipeline to its partners. LFB USA's rpro technology is revolutionizing recombinant protein production for a new generation of therapeutics. The company is ultimately controlled by the Government of France. Jose Antonio Moreno Toscano has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member | |
Levicept Ltd.
 Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Generic | Director/Board Member | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chairman | |
| FOGHORN THERAPEUTICS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chairman | |
| Janssen Therapeutics, Inc. | President | ||
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Founder | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Pomerantz Life Sciences Consulting Group LLC | President | ||
| MODERNA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
Citryll BV
 Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Miscellaneous Commercial Services | Chairman | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| VIRACTA THERAPEUTICS, INC. | Biotechnology | Chairman | |
Ampersand Biomedicines
 Ampersand Biomedicines BiotechnologyHealth Technology Ampersand Biomedicines is an American company that designs programmable medicines that work precisely where needed in the body and nowhere else. The company's computationally powered platform identifies ideal addresses for drug localization and informs the design of and-body™ therapeutics that have the optimal therapeutic effect. The result is smarter biologic medicines that target the site of disease without affecting healthy tissue or cells. Ampersand is enabling potent mechanisms to treat disease by creating and programming therapeutics that are more efficacious, without compromising on safety or tolerability. The company was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Jason Gardner has been the CEO of the company since 2023. | Biotechnology | President | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman |
Statistieken
Internationaal
| Verenigde Staten | 39 |
| Verenigd Koninkrijk | 5 |
| Israël | 4 |
| India | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 10 |
| Commercial Services | 7 |
| Health Services | 2 |
| Finance | 2 |
Operationeel
| Director/Board Member | 87 |
| Corporate Officer/Principal | 37 |
| Undergraduate Degree | 29 |
| Chairman | 27 |
| Private Equity Investor | 25 |
Sterkste connecties
| Insiders | |
|---|---|
| Roger Pomerantz | 30 |
| John Mendlein | 27 |
| Theo Melas-Kyriazi | 26 |
| Jim Matheson | 19 |
| Brian M. Baynes | 18 |
| Paul-Peter Tak | 15 |
| Robert Connelly | 15 |
| Yann Echelard | 11 |
| Carl Decicco | 8 |
| Jason Pontin | 8 |
| Zack Armen | 7 |
| Peter Marc Fong | 5 |
| Michael Mee | 5 |
| Yajie Niu | 5 |
| Ben Portney | 5 |
- Beurs
- Insiders
- Ellen van Rooijen
- Bedrijfsconnecties
